SEC Form 4 · accession 0001209191-17-034764
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred E Cohen
Director
Period of report
May 19, 2017
Accepted (ET)
May 23, 2017 · 8:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 19, 2017 | M | 8,250 | $14.37 | A | 74,145 | D | |
| Common StockF1,F2 | May 19, 2017 | S | 8,250 | $29.5448 | D | 65,895 | D | |
| Common Stock | holding | — | — | — | 6,068 | I | By the Jane K Cohen Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy) | $14.37 | May 19, 2017 | M | 8,250 | D | Jun 11, 2011 | Jun 11, 2020 | Common Stock | 0 | 0 | D |
Explanation of responses
- F1Represents weighted average sale price. Actual sale prices ranged from $29.35 to $29.80.
- F2Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.